Population approaches in drug development
✍ Scribed by L. Aarons; L. P. Balant; F. Mentré; P. L. Morselli; M. Rowland; J. -L. Steimer; S. Vozeh
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 322 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
✦ Synopsis
European d ..... [of (~r}~(~(~
📜 SIMILAR VOLUMES
Nanomedicine is at the cutting edge of science, pushing the frontiers of chemistry, engineering, materials science, biochemistry, and molecular biology. Because the research and technology development are on the nanometer scale, small molecules are the most obvious tools to use to manipulate molecul
The clinical phase of drug development should be concluded sooner and at a lower cost if primarily only the pivotal and supportive studies were to be conducted. Such improved efficiency requires development of a decision support system that delivers five new capabilities: (i) it enables one to predi